Warner-Lambert Working on Drug That Could Prevent Neuropathy

| Apr 1, 1999

Warner-Lambert is now testing a potential drug it calls Zenarestat that could prevent neuropathy. Several medications treat neuropathy pain, but according to Howard Foyt, MD, PhD, director of clinical research, diabetes and metabolic diseases for Warner-Lambert, there is none available for preventing or reducing the risk of neuropathy.

"Right now, doctors prescribe antidepressants, capsaicin or even Neurontin [a Warner-Lambert drug used for the treatment of epilepsy] to treat neuropathy-related pain," explains Foyt. "None of these affects the natural history of diabetes, or does anything to inhibit the progression of the disease."

Zenarestat is an aldose reductase inhibitor (ARI) that, according to Warner-Lambert, reduces sorbitol levels in human tissues and improves nerve fiber density. According to Foyt, blood sugar can become sorbitol in a person with diabetes, which can lead to neuropathy, kidney disease and retinopathy complications.

About 60 percent of people with diabetes suffer from some type of nerve damage.

"Zenarestat is a second-generation ARI which has been documented to get into the tissues and nerves, and significantly lower sorbitol levels without causing skin reactions or liver toxicity," says Foyt.

Nerve conduction velocity (how fast a nerve conducts electrical impulses) increased by 1 to 1.5 meters per second over the 12-month test period in people who took Zenarestat, while a placebo group's nerve conduction velocity decreased. Additionally, nerve fiber density increased in the Zenarestat group and decreased in the placebo group.

"Any patient with diabetes, even if he or she has excellent glycemic control, is still at risk for neuropathy complications," says Foyt. "By reducing sorbitol levels, this drug is aimed at further reducing your risk for either the development or progression of diabetic neuropathy."

Warner-Lambert is in the final stages of testing for Zenarestat. Presently, there is one study in the United States and one in Europe. Based on the results of those studies, Warner-Lambert will apply for FDA approval.

Click Here To View Or Post Comments

Categories: Blood Sugar, Diabetes, Nerve Care (Neuropathy)


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Apr 1, 1999

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.